title: Helicobacter pylori infection and inflammatory bowel disease: is there a link?
abstract: Helicobacter pylori (H. pylori) infection is one of the most widely spread infectious diseases in humans. It can cause chronic gastritis, peptic ulcer disease and gastric malignancies and has been associated with extra-gastric disorders. H. pylori elicit a chronic systemic inflammatory response which, under certain conditions, may trigger autoimmune reactions and may be implicated in the pathogenesis of autoimmune diseases. Although the pathogenesis of inflammatory bowel disease (IBD) is unknown, it is thought to result from complex interactions between environmental factors and microbiota in the gut of individuals who are genetically susceptible. Several bacterial and viral agents have been implicated in the aetiology of IBD. In theory, H. pylori infection could be involved in the pathogenesis of IBD by inducing alterations in gastric and/or intestinal permeability or by causing immunological derangements resulting in absorption of antigenic material and autoimmunity via various immunological pathways. Similar mechanisms may also be responsible for the co-existence of IBD with other autoimmune diseases and/or extra-intestinal manifestations. However, the epidemiological data fail to support this association. In fact, various studies indicate that the prevalence of H. pylori infection is low in patients with IBD, suggesting a protective role for this infection in the development of IBD. In this report, we aim to shed light on proposed mechanisms and confounding factors underlying the potential link between H. pylori infection and IBD.
authors.affiliation: Konstantinos Papamichael, Panagiotis Konstantopoulos, Gerassimos J Mantzaris, First Gastroenterology Clinic, Evaggelismos Hospital, 10676 Athens, Greece.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Papamichael
authors.affiliation: Konstantinos Papamichael, Panagiotis Konstantopoulos, Gerassimos J Mantzaris, First Gastroenterology Clinic, Evaggelismos Hospital, 10676 Athens, Greece.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Konstantopoulos
authors.affiliation: Konstantinos Papamichael, Panagiotis Konstantopoulos, Gerassimos J Mantzaris, First Gastroenterology Clinic, Evaggelismos Hospital, 10676 Athens, Greece.
authors.forename: Gerassimos J
authors.initials: GJ
authors.lastname: Mantzaris
mesh_terms: D003093:Colitis, Ulcerative / Q000150:complications / Q000382:microbiology; D015179:Colorectal Neoplasms / Q000150:complications / Q000382:microbiology; D015897:Comorbidity; D003424:Crohn Disease / Q000150:complications / Q000382:microbiology; D005756:Gastritis / Q000150:complications / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D007107:Immune System; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000382:microbiology*; D015995:Prevalence
keywords: Colorectal cancer; Crohn’s disease; Helicobacter pylori; Inflammatory bowel disease; Ulcerative colitis